Skip to main content
Explore URMC

Sara J. Hardy, M.D.

Contact Information

Phone Numbers

Appointment: (585) 276-3000

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments

Patient Care Settings

Neurology, Radiation Oncology




    MD | Case Western Reserve University

    Post-doctoral Training & Residency

    07/01/2016 - 06/30/2020
    Residency in Radiation Oncology at University of Rochester Medical Center

    07/01/2012 - 06/30/2015
    Residency in Neurology at Johns Hopkins Bloomberg School of Public Health

    06/23/2011 - 06/30/2012
    Internship in Internal Medicine at Fletcher Allen Health Care-MCHV Campus (USA)

    VIEW ALL expand_more


    Holman Research Pathway

    Roentgen Resident/Fellow Research Award
    Sponsor: Radiological Society of North America

    2017 - 2019
    Red Journal Reviewer Trainee Program
    Sponsor: American Society for Therapeutic Radiation Oncology

    Seed Grant Award
    Sponsor: American Medical Association

    2001 - 2005
    National Merit Scholar

    VIEW ALL expand_more

    Clinical Trials

    Early Telehealth Visits for Discussion of Advanced Directives for Patients Newly Diagnosed With High Grade Glioma: Impact on Patient Care and Satisfaction

    Lead Researcher: Sara J Hardy

    High grade gliomas (HGGs) are rapidly progressive brain tumors resulting in death for most patients between 6 months and 2 years after diagnosis. It is important for patients with HGG to discuss and document their wishes at the end of life. However, many of these patients experience early changes in cognition which impede their decision-making. For this reason, these patients should have early discussions with their providers. However, implementation of this remains challenging in clinical practice. In this study, we will create an Early STructured Advanced care Referrals by Telehealth (Early START) visit for patients soon after their initial oncology visit. A checklist and pre-visit guide were developed to help guide the visit for both the provider and patient. Providers will receive special training in running these visits. Caregivers and/or family members will be encouraged to participate. Visits will be done using video or telephone and recorded. For patients who do not have access to technology for these visits, it will be provided. After the visit, patients, caregivers and/or family who participated, and providers will fill out surveys to address feasibility of having these extra visits and improve the visits for future. Patients will be followed until death. Caregivers and/or family who participated will be asked about whether end of life was in line with the patient's wishes. We will also use the patient's medical record to assess other aspects of end of life. We will compare end of life outcomes with other similar patients treated at our center.

    View Study Details


    Journal Articles

    Belcher EK, Culakova E, Gilmore NJ, Hardy SJ, Kleckner AS, Kleckner IR, Lei L, Heckler C, Sohn MB, Thompson BD, Lotta LT, Werner ZA, Geer J, Hopkins JO, Corso SW, Rich DQ, van Wijngaarden E, Janelsins MC. "Inflammation, Attention, and Processing Speed in Patients with Breast Cancer before and after Chemotherapy." Journal of the National Cancer Institute.. 2022 Feb 4; Epub 2022 Feb 04.

    Milano MT, Bates JE, Budnik J, Qiu H, Hardy S, Cummings MA, Baumgart MA, Maggiore RJ, Mulford DA, Usuki KY. "Risk of brain metastases in T1-3N0 NSCLC: a population-based analysis." Lung cancer management.. 2020 Feb 25; 9(1):LMT25. Epub 2020 Feb 25.

    Milano MT, Hardy SJ, Chowdhry AK. "Nivolumab without brain radiotherapy is insufficient for the treatment of most patients with brain metastases from clear cell renal cell carcinoma." Annals of translational medicine.. 2019 Dec; 7(Suppl 8):S366.

    Books & Chapters

    Chapter Title: Hypopituitarism
    Book Title: Adult CNS Radiation Oncology
    Author List: Hardy S; Shafiq I; Milano M; Vates E; Constine L
    Published By: Springer International Publishing AG 2018